VASTox Signs Drug Discovery Deals Worth a Combined US$1.3 M
Business Review Editor
Abstract
VASTox signed two deals worth a combined value of €1 M. VASTox formed a drug discovery and toxicology screening agreement with Rottapharm. In a deal with an unnamed European biotech, VASTox’s will support one of the client’s drug discovery programs.
Full Text: pdf
Add comment

This work is licensed under a Creative Commons Attribution 3.0 License.